Q-Cells SE · Bitterfeld-Wolfen Germany (German: QCE)
Key Q-Cells SE Financials
| Company Type | Public -(German: QCE) Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Sales (mil.) | $1,794.6 |
| 2010 Employees | 2,490 |
Q-Cells SE Income Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Revenue | 1,794.6 | 1,148.9 | 1,763.7 |
| Cost of Goods Sold | 1,534.3 | 1,130.5 | 1,262.3 |
| Gross Profit | 260.3 | 18.3 | 501.4 |
| Gross Profit Margin | 14.5% | 1.6% | 28.4% |
| SG&A Expense | -- | -- | 125.7 |
| Depreciation & Amortization | -- | -- | -- |
| Operating Income | 109.1 | (696.4) | 289.1 |
| Operating Margin | 6.1% | -60.6% | 16.4% |
| Nonoperating Income | 76.7 | (441.1) | (4.4) |
| Nonoperating Expenses | (37.0) | (105.6) | 32.7 |
| Income Before Taxes | 148.8 | (1,243.2) | 317.4 |
| Income Taxes | (28.4) | 118.7 | (53.4) |
| Net Income After Taxes | 177.2 | (1,361.8) | 370.8 |
| Continuing Operations | 120.5 | (1,124.5) | 264.0 |
| Discontinued Operations | (102.2) | (861.2) | -- |
| Total Operations | 18.3 | (1,985.7) | 264.0 |
| Total Net Income | 18.3 | (1,985.7) | 264.0 |
| Net Profit Margin | 1% | -172.8% | 15% |
| Diluted EPS from Total Net Income | 0.19 | (16.93) | 2.38 |
| Dividends per Share | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
Q-Cells SE Balance Sheet
| Assets | Dec 10 | Dec 09 | Dec 08 |
| Current Assets | |||
| Cash | 628.0 | 590.3 | 248.9 |
| Net Receivables | -- | -- | -- |
| Inventories | 484.6 | 433.0 | 305.6 |
| Other Current Assets | 340.0 | 426.2 | 496.7 |
| Total Current Assets | 1,452.7 | 1,449.5 | 1,051.2 |
| Net Fixed Assets | 1,166.4 | 1,209.0 | 936.8 |
| Other Noncurrent Assets | 269.0 | 534.2 | 2,008.1 |
| Total Assets | 2,888.1 | 3,192.7 | 3,996.1 |
| Liabilities | Dec 10 | Dec 09 | Dec 08 |
| Current Liabilities | |||
| Accounts Payable | 197.2 | 143.0 | 112.3 |
| Short-Term Debt | -- | -- | -- |
| Other Current Liabilities | 433.1 | 596.2 | 432.7 |
| Total Current Liabilities | 630.3 | 739.2 | 545.1 |
| Long-Term Debt | -- | -- | -- |
| Other Noncurrent Liabilities | 1,088.1 | 1,397.2 | 805.8 |
| Total Liabilities | 1,718.4 | 2,136.5 | 1,350.9 |
| Shareholder's Equity | |||
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | 1,169.8 | 1,056.3 | 2,603.3 |
| Total Equity | 1,169.8 | 1,056.3 | 2,603.3 |
| Shares Outstanding (thou.) | 149,461.7 | 88,974.6 | 82,929.0 |
All amounts in millions of US Dollars except per share amounts.
Q-Cells SE Cash Flow Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Net Operating Cash Flow | 93 | (158) | (340) |
| Net Investing Cash Flow | (29.4) | 65.1 | (339.7) |
| Net Financing Cash Flow | (115.8) | 376.9 | 337.7 |
| Net Change in Cash | (52.2) | 284.5 | (341.9) |
| Depreciation & Amortization | |||
| Capital Expenditures | (157.3) | (444.6) | (474.0) |
| Cash Dividends Paid | 0.0 | (1.3) | (1.3) |
All amounts in millions of US Dollars except per share amounts.